Novo Nordisk Expands Research in China

  • Author: ChemistryViews
  • Published: 26 September 2012
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
  • Source / Publisher: Novo Nordisk A/S
thumbnail image: Novo Nordisk Expands Research in China

Novo Nordisk invests an additional $100 million to expand its research facilities in Beijing, China. The new 12,000-m2 center will make an increase from 130 to 200 science employees possible, with extra space available to accommodate additional future growth.


Novo Nordisk was the first multinational company to open a research center in China in 1997. The site in Beijing has already contributed significantly to the company’s research and development portfolio in both diabetes and biopharmaceutical target disease areas. The new, expanded facility will enable even stronger contributions from the science team in China across the range of Novo Nordisk’s protein technology, biology and pharmacology research activities.


Article Views: 1726

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH